PEAK6’s BioNTech BNTX Stock Holding History

PEAK6’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.7M	Buy	131,800 +81,800	+164%	+$8.41M	0.03%	526
2025 Q4	$4.76M	Buy	+50,000	New	+$5.04M	0.01%	961

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PEAK6's BNTX Position: Q1 2026 in Review

PEAK6 increased its BioNTech (BNTX) stake by 72% in Q1 2026, buying an estimated $1.86M and bringing the position to 43,054 shares worth $3.83M. The position accounts for 0.01% of the portfolio, ranked #1030.

PEAK6 first reported a position in BNTX in Q4 2024 and has held it in 4 quarters since. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

PEAK6 held 43,054 shares of BioNTech worth $3.83M as of Q1 2026.
PEAK6 bought 18,054 BioNTech shares in Q1 2026, an estimated $1.86M.
BioNTech made up 0.01% of PEAK6's portfolio in Q1 2026, its #1030 holding.
PEAK6 first reported a position in BioNTech in Q4 2024 and has held it in 4 quarters since.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.